“Neutrophil Activation Marker CD15+ As a Prognostic Factor of Ocular Surface Damage in Type 2 Diabetics”. 2024. Ukrainian Journal of Ophthalmology , no. 1 (February): 15-19. https://doi.org/10.31288/oftalmolzh202411519.